Assessment of cholesterol homeostasis in the living human brain
- 5 October 2022
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 14 (665) , eadc9967
Abstract
Alterations in brain cholesterol homeostasis have been broadly implicated in neurological disorders. Notwithstanding the complexity by which cholesterol biology is governed in the mammalian brain, excess neuronal cholesterol is primarily eliminated by metabolic clearance via cytochrome P450 46A1 (CYP46A1). No methods are currently available for visualizing cholesterol metabolism in the living human brain; therefore, a noninvasive technology that quantitatively measures the extent of brain cholesterol metabolism via CYP46A1 could broadly affect disease diagnosis and treatment options using targeted therapies. Here, we describe the development and testing of a CYP46A1-targeted positron emission tomography (PET) tracer, 18 F-CHL-2205 ( 18 F-Cholestify). Our data show that PET imaging readouts correlate with CYP46A1 protein expression and with the extent to which cholesterol is metabolized in the brain, as assessed by cross-species postmortem analyses of specimens from rodents, nonhuman primates, and humans. Proof of concept of in vivo efficacy is provided in the well-established 3xTg-AD murine model of Alzheimer’s disease (AD), where we show that the probe is sensitive to differences in brain cholesterol metabolism between 3xTg-AD mice and control animals. Furthermore, our clinical observations point toward a considerably higher baseline brain cholesterol clearance via CYP46A1 in women, as compared to age-matched men. These findings illustrate the vast potential of assessing brain cholesterol metabolism using PET and establish PET as a sensitive tool for noninvasive assessment of brain cholesterol homeostasis in the clinic.Keywords
This publication has 70 references indexed in Scilit:
- The Amyloid Precursor Protein Has a Flexible Transmembrane Domain and Binds CholesterolScience, 2012
- Comparative Lipidomic Analysis of Mouse and Human Brain with Alzheimer DiseaseJournal of Biological Chemistry, 2012
- Plasma 24S-hydroxycholesterol levels in elderly subjects with late onset Alzheimer's disease or vascular dementia: a case-control studyBMC Neurology, 2011
- Linking lipids to Alzheimer's disease: cholesterol and beyondNature Reviews Neuroscience, 2011
- Structural Basis of Drug Binding to CYP46A1, an Enzyme That Controls Cholesterol Turnover in the BrainJournal of Biological Chemistry, 2010
- Adeno-associated Virus Gene Therapy With Cholesterol 24-Hydroxylase Reduces the Amyloid Pathology Before or After the Onset of Amyloid Plaques in Mouse Models of Alzheimer's DiseaseMolecular Therapy, 2010
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingJournal of Computational Chemistry, 2009
- A population-average MRI-based atlas collection of the rhesus macaqueNeuroImage, 2009
- Crystal structures of substrate-bound and substrate-free cytochrome P450 46A1, the principal cholesterol hydroxylase in the brainProceedings of the National Academy of Sciences, 2008
- Polymorphism in the cholesterol 24S-hydroxylase gene is associated with Alzheimer's diseaseMolecular Psychiatry, 2002